Author: Macaluso, Fabio Salvatore; Orlando, Ambrogio
Title: COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW OF CLINICAL DATA Cord-id: sr2zbfnc Document date: 2020_9_6
ID: sr2zbfnc
Snippet: BACKGROUND: Great efforts by the scientific community are rapidly expanding the evidence on the clinical interplay between Covid-19 and inflammatory bowel disease (IBD). AIMS: We performed a systematic review of the literature on published Covid-19 cases occurring in patients with IBD. METHODS: PubMed Central/Medline and Embase were systemically searched for records up to May 31, 2020. RESULTS: 13 cohort studies and 5 single case reports were included in the qualitative synthesis. A cumulative n
Document: BACKGROUND: Great efforts by the scientific community are rapidly expanding the evidence on the clinical interplay between Covid-19 and inflammatory bowel disease (IBD). AIMS: We performed a systematic review of the literature on published Covid-19 cases occurring in patients with IBD. METHODS: PubMed Central/Medline and Embase were systemically searched for records up to May 31, 2020. RESULTS: 13 cohort studies and 5 single case reports were included in the qualitative synthesis. A cumulative number of approximately 800 patients with IBD and Covid-19 were identified. The case fatality rate ranged from 0% to 20.0%. Overall, immunomodulators and biologics were not associated with higher risk of Covid-19 or with negative outcomes, while the the use of systemic corticosteroids was related to worse prognosis in some studies. CONCLUSIONS: This systematic review highlighted two main points that may help clinicians dealing with IBD in reassuring their patients: (1) patients with IBD do not seem to be at higher risk of being infected by SARS-COV-2 than the general population; (2) in case of Covid-19, treatment with immunomodulators or biologics is not associated with worse prognosis, while systemic steroids are suspected to be potentially detrimental, even if more data are needed to confirm this point.
Search related documents:
Co phrase search for related documents- abstract title and acute respiratory syndrome sars: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- abstract title and additional study: 1, 2
- abstract title and logistic regression: 1, 2, 3, 4
- abstract title and lopinavir ritonavir: 1, 2
- active ibd and acute respiratory: 1
- active ibd and acute respiratory syndrome sars: 1
- active ibd and acute severe ulcerative colitis: 1, 2, 3
- active ibd and additional study: 1
- active ibd and logistic regression: 1, 2, 3, 4
- active ibd and logistic regression analysis: 1, 2, 3
- acute respiratory and adalimumab treatment: 1
- acute respiratory and additional study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and madrid san carlos: 1, 2
- acute respiratory and madrid san carlos hospital clinico: 1, 2
- acute respiratory syndrome sars and madrid san carlos: 1
- acute respiratory syndrome sars and madrid san carlos hospital clinico: 1
Co phrase search for related documents, hyperlinks ordered by date